Akèy › Gliyoblastòm › Minnesota › Rochester
Etid klinik pou Gliyoblastòm nan Rochester, MN
13 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Ap rekriteFaz 2
- Mayo Clinic in Rochester, Rochester
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Ap rekriteFaz 1/2
- Mayo Clinic in Rochester, Rochester
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
- Mayo Clinic - Rochester, Rochester
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
Ap rekriteFaz 1 bonè
- Mayo Clinic in Rochester, Rochester
Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions
Ap rekrite
- Mayo Clinic in Rochester, Rochester
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Ap rekrite
- Mayo Clinic in Rochester, Rochester
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
Ap rekrite
- Mayo Clinic in Rochester, Rochester
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Ap rekriteFaz 2
- Mayo Clinic, Rochester
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Ap rekriteFaz 1/2
- Mayo Clinic in Rochester, Rochester
ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
Ap rekriteFaz 1
- Mayo Clinic in Rochester, Rochester
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
Ap rekriteFaz 1/2
- Mayo Clinic Hospital, Rochester
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Ap rekriteFaz 1/2
- Mayo Clinic Cancer Center, Rochester
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Ap rekriteFaz 2
- Mayo Clinic, Rochester
Etid Gliyoblastòm nan lòt vil
- New York City, NY30 etid
- Boston, MA28 etid
- Houston, TX26 etid
- Los Angeles, CA24 etid
- Durham, NC20 etid
- San Francisco, CA17 etid
- Chicago, IL15 etid
- Washington, DC15 etid
- Columbus, OH14 etid
- Miami, FL14 etid
- Jacksonville, FL13 etid
- Aurora, CO12 etid
Lòt etid nan Rochester
- Kansè nan tete42 etid
- Kansè Poumon ki pa ti selil37 etid
- Kansè Metastatik31 etid
- Kansè (tout kalite)30 etid
- Kansè ovè29 etid
- Kansè kolorektal29 etid
- Myelom Miltip24 etid
- Ensifizyans kadyak22 etid
- Kansè pwostat22 etid
- Kansè pankreyas22 etid
- Kansè Endomèt20 etid
- Kansè poumon20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.